In recent years, many studies have shown that the PI3K/AKT signalling pathway is abnormally activated in a variety of malignant tumours and that abnormal activation of this pathway is clearly associated with tumourigenesis, cancer progression, and drug resistance 24. The gene discussed is AKT1; the disease is cancer.